Ardelyx (ARDX) Director Mott Buys $1M in Stock Following Positive FDA Panel

November 17, 2022 4:14 PM EST Send to a Friend

Ardelyx (NASDAQ: ARDX) Director, David Mott ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Ardelyx (ARDX) Director Mott Buys $1M in Stock Following Positive FDA Panel

Member Login

Free News Feed